CSPC Pharmaceutical Group Limited Market Cap ($10.04 Billion)
Market Cap & Net Worth: CSPC Pharmaceutical Group Limited (CVG)
CSPC Pharmaceutical Group Limited market cap. CSPC Pharmaceutical Group Limited (F:CVG) has a market capitalization of $10.04 Billion (€8.59 Billion) as of November 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #2166 globally and #461 in its home market, demonstrating a -5.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CSPC Pharmaceutical Group Limited's stock price €0.88 by its total outstanding shares 11405451732 (11.41 Billion). Also see CSPC Pharmaceutical Group Limited cash conversion from operations for how efficiently the company converts equity into cash flow.
CSPC Pharmaceutical Group Limited Market Cap History (2015–2026)
CSPC Pharmaceutical Group Limited market cap history from 2015 to 2026. Data shows growth from $1.07 Billion to $11.73 Billion (26.18% CAGR). Check CVG share price today for real-time trading data and today's change.
CSPC Pharmaceutical Group Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CSPC Pharmaceutical Group Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore CVG year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.47x
CSPC Pharmaceutical Group Limited's market cap is 0.47 times its annual revenue
Latest Price to Earnings (P/E) Ratio
3.13x
CSPC Pharmaceutical Group Limited's market cap is 3.13 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $1.31 Billion | $11.08 Billion | $1.88 Billion | 0.12x | 0.70x |
| 2017 | $2.44 Billion | $12.92 Billion | $2.32 Billion | 0.19x | 1.06x |
| 2018 | $1.89 Billion | $18.47 Billion | $3.21 Billion | 0.10x | 0.59x |
| 2019 | $3.71 Billion | $22.10 Billion | $3.71 Billion | 0.17x | 1.00x |
| 2020 | $3.25 Billion | $24.94 Billion | $5.16 Billion | 0.13x | 0.63x |
| 2021 | $4.37 Billion | $27.87 Billion | $5.61 Billion | 0.16x | 0.78x |
| 2022 | $5.71 Billion | $30.94 Billion | $6.09 Billion | 0.18x | 0.94x |
| 2023 | $7.03 Billion | $31.45 Billion | $5.87 Billion | 0.22x | 1.20x |
| 2024 | $7.69 Billion | $29.01 Billion | $4.33 Billion | 0.27x | 1.78x |
| 2025 | $12.13 Billion | $26.01 Billion | $3.88 Billion | 0.47x | 3.13x |
Competitor Companies of CVG by Market Capitalization
Companies near CSPC Pharmaceutical Group Limited in the global market cap rankings as of November 4, 2026. Also see CSPC Pharmaceutical Group Limited assets under control for a full breakdown of the balance sheet.
Key companies related to CSPC Pharmaceutical Group Limited by market ranking:
- Eli Lilly and Company (NYSE:LLY): Ranked #12 globally with a market cap of $1.06 Trillion USD.
- Eli Lilly and Company (SA:LILY34): Ranked #20 globally with a market cap of $853.51 Billion USD ( R$4.35 Trillion BRL).
- Johnson & Johnson (NYSE:JNJ): Ranked #29 globally with a market cap of $574.95 Billion USD.
- AbbVie Inc (NYSE:ABBV): Ranked #42 globally with a market cap of $356.49 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #12 | Eli Lilly and Company | NYSE:LLY | $1.06 Trillion | $1410.99 |
| #20 | Eli Lilly and Company | SA:LILY34 | $853.51 Billion | R$153.70 |
| #29 | Johnson & Johnson | NYSE:JNJ | $574.95 Billion | $270.56 |
| #42 | AbbVie Inc | NYSE:ABBV | $356.49 Billion | $288.84 |
Market Capitalization of CSPC Pharmaceutical Group Limited (2015–2026)
Market capitalization of CSPC Pharmaceutical Group Limited from 2015 to today. Between 2015 and today, CSPC Pharmaceutical Group Limited's market cap moved from $1.07 Billion to $ 11.73 Billion, with a yearly change of 26.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €11.73 Billion | -3.36% |
| 2025 | €12.13 Billion | +57.77% |
| 2024 | €7.69 Billion | +9.37% |
| 2023 | €7.03 Billion | +23.17% |
| 2022 | €5.71 Billion | +30.79% |
| 2021 | €4.37 Billion | +34.35% |
| 2020 | €3.25 Billion | -12.43% |
| 2019 | €3.71 Billion | +96.12% |
| 2018 | €1.89 Billion | -22.54% |
| 2017 | €2.44 Billion | +86.56% |
| 2016 | €1.31 Billion | +21.99% |
| 2015 | €1.07 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of CSPC Pharmaceutical Group Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.04 Billion USD |
| MoneyControl | $10.04 Billion USD |
| MarketWatch | $10.04 Billion USD |
| marketcap.company | $10.04 Billion USD |
| Reuters | $10.04 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CSPC Pharmaceutical Group Limited
CSPC Pharmaceutical Group Limited, an investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally. It operates through Finished Drugs, Bulk Products, and Functional Food and Others segments. The company provides NBP soft capsules and injections for acute ischemic stroke; Oulaining cap… Read more